____________________ By virtue of Section 16/6 and Section 113 of the Securities and Exchange Act B.E. 2535 (1992), as amended by the Securities and Exchange Act (No. 4) B.E. 2551 (2008), Section 114 and Section 116 of
all securities of the Company (comprising the Company’s ordinary shares, the GSTEL-W1 warrants, GSTEL-W2 warrants, and G-STEL-W3 warrants) as prescribed in the Securities and Exchange Act B.E. 2535 (as
Report Form 69-1 1 September 2020 Note : This annual registration statement / annual report (Form 56-1 One Report) contains minimum information required to be disclosed by the issuing company (“Company
by the issuing company (“Company”). Preparation and filing thereof should also take into consideration the guidelines, the manual or the disclosure checklist available on the SEC website. - 2 - SEC
Assets of Wattanapat Hospital Trang Public Company Limited As Wattanapat Hospital Trang Public Company Limited (“the Company”) had approved the resolution of its Board of Director’s Meeting No.4/2019 held
์ - 34-0135 www.interpharma.co.th Inter Pharma Public Company Limited 140/9 ITF Tower, 9th Floor, Silom Road, Suriyawongse, Bangrak, Bangkok 10500, Thailand. Tel. 02-634-0225 Fax 02-634-0135
proposal for amendment of the Articles of Association of the Company was made to ensure consistency with the Public Limited Companies Act (No. 2) B.E. 2544 (2001) in relation to amendment of matters which
Section 75 of the Derivatives Act B.E. 2546 (2003), which contains certain provisions in relation to the restriction of right and liberty of person which Section 29 in conjunction with Section 33, Section